Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Small cell carcinoma
ADR ID BADD_A07702
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.017      Small cell carcinoma
Description An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) [MeSH]
MedDRA Code 10041056
MeSH ID D018288
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Small cell carcinoma | Small cell carcinoma metastatic | Carcinoma, Small Cell | Carcinomas, Small Cell | Small Cell Carcinomas | Oat Cell Carcinoma | Small Cell Carcinoma | Carcinoma, Oat Cell | Carcinomas, Oat Cell | Oat Cell Carcinomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.000501%
BADD_D00047Afatinib0.000392%
BADD_D00271Bicalutamide0.002109%
BADD_D00511Clozapine0.001223%
BADD_D01260Leuprolide acetate0.001434%
BADD_D01913Ranitidine0.000025%
BADD_D02105Tacrolimus0.000297%
The 1th Page    1    Total 1 Pages